|
Volumn 46, Issue 2, 2000, Pages 338-341
|
Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis [11]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
CLOTRIMAZOLE;
CYCLODEXTRIN DERIVATIVE;
CYTOCHROME P450;
DIMETHYL SULFOXIDE;
FLUCONAZOLE;
FUNGAL ENZYME;
ITRACONAZOLE;
KETOCONAZOLE;
N DEMETHYLASE;
PYRROLE DERIVATIVE;
VORICONAZOLE;
CANDIDA ALBICANS;
CANDIDA KRUSEI;
CANDIDA PARAPSILOSIS;
CANDIDIASIS;
CHILD;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CROSS RESISTANCE;
DRUG BINDING;
DRUG RESISTANCE;
DRUG SENSITIVITY;
FUNGUS CULTURE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KARYOTYPING;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
OROPHARYNX;
POLYMERASE CHAIN REACTION;
RANDOM AMPLIFIED POLYMORPHIC DNA;
RECURRENT DISEASE;
STRAIN DIFFERENCE;
ANTIFUNGAL AGENTS;
AZOLES;
CANDIDA ALBICANS;
CANDIDIASIS, ORAL;
CHILD;
DRUG RESISTANCE, MICROBIAL;
HIV INFECTIONS;
HUMANS;
|
EID: 0033898261
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (89)
|
References (6)
|